:::

學術成果

:::
搜尋
年至

月至


  • 關鍵字搜尋
  • 期刊論文
    學年度著作著作人
    101Dore D, Seeger J, Chan KA.,2012,Incidence of health insurance claims for thyroid neoplasm and pancreatic malignancy in association with exenatide: signal refinement using active safety surveillance., Therapeutic Advances in Drug Safety ,3,pp157-164 (SCI)陳建煒
    101Chang C-H, Lin J-W, Wu L-C, Lai M-S, Chuang L-M, Chan KA. ,2012,Association of thiazolidinediones with liver cancer and colorectal cancer in type 2 diabetes mellitus.,Hepatology,55,5,pp1462-1472 (SCI)陳建煒
    100Thongprasert S, Duffield E, Saijo N, Wu YL, Yang CH, Chu DT, Lia M, Chen YM, Kuo HP, Negoro S, Lam KC, Armour A, Magill R and Fukuoka M. ,2011,Health-related quality-of-life in a randomized phase III first-line study of gefitinib versus carboplatin/paclitaxel in clinically selected patients from Asia with advanced NSCLC.,J Thorac Oncol,6,11,pp1872-1880 (SCI)楊志新
    100Medema RH, Lin CC, Yang JC*.,2011,Polo-like kinase 1 inhibitors and their potential role in anticancer therapy, with a focus on NSCLC.(Review article),Clin Cancer Res. ,17,20,pp6459-6466 (SCI)楊志新
    100Wu YL, Park K, Soo RA, Sun Y, Tyroller K, Wages D, Ely G, Yang JC, Mok T.,2011,INSPIRE: A phase III study of the BLP25 liposome vaccine (L-BLP25) in Asian patients with unresectable stage III non-small cell lung cancer.,BMC Cancer.,11,pp430- (SCI)楊志新
    100de Boer RH, Arrieta O, Yang CH, Gottfried M, Chan V, Raats J, DeMarinis F, Abratt RP, Wolf J, Blackhall FH, Langmuir P, Milenkova T, Read J and Vansteenkiste J ,2011,Vandetanib plus pemetrexed for the second-line treatment of advanced non-small-cell lung cancer: a randomized, double-blind phase III trial (ZEAL) ,J Clin Oncol,39,8,pp1067-1074 (SCI)楊志新
    100Chen CY, Chang YL, Shih JY, Lin JW, Chen KY, Yang CH, Yu CJ and Yang PC.,2011,Thymidylate synthase and dihydrofolate reductase expression in nonsmall cell lung cancer carcinoma: the association with treatment efficacy of pemetrexed.,Lung Cancer,74,1,pp132-138 (SCI)楊志新
    100Tan EH, Goss GD, Salgia R, Besse B, Gandara DR, Hanna NH, Yang JC, Thertulien R, Wertheim M, Mazieres J, Hensing T, Lee C, Gupta N, Pradhan R, Qian J, Qin Q, Scappaticci RA, Ricker JL, Garson DM, Soo RA.,2011,Phase II trial of Linifanib (ABT-869) in patients with advanced nonsmall cell lung cancer.,J Thorac Oncol.,6,8,pp1418-1425 (SCI)楊志新
    100Wu JY, Yu CJ, Chang YC, Yang CH, Shih JY and Yang PC. ,2011,Effectiveness of tyrosine kinase inhibitors on "uncommon" epidermal growth factor receptor mutations of unknown clinical significance in non-small cell lung cancer.,Clin Can Res.,17,11,pp3812-3821 (SCI)楊志新
    100Lin ZZ and Yang CH*.,2011,Current Roles and Future Perspectives of Epidermal Growth Factor Receptor Tyrosine Kinase Inhibitors in Advanced Non-Small-Cell Lung Cancer.(Review article),Eur J Clin Med Oncol (SCI)楊志新